Science O O O O
& O O O O
Tech O O O O
Spotlight: O O O O
COVID-19 O O O O
Vaccine O O O O
Development O O O O
[Updated O O O O
on O O O O
June O O O O
29, O O O O
2021] O O O O
[This O O O O
is O O O O
an O O O O
update O O O O
to O O O O
the O O O O
previous O O O O
COVID-19 O O O O
vaccine O O O O
development O O O O
spotlight. O O O O
It O O O O
was O O O O
updated O O O O
to O O O O
include O O O O
new O O O O
and O O O O
updated O O O O
information O O O O
on O O O O
the O O O O
federal O O O O
effort O O O O
to O O O O
support O O O O
the O O O O
development, O O O O
manufacture, O O O O
and O O O O
delivery O O O O
of O O O O
COVID-19 O O O O
vaccines. O O O O
The O O O O
PDF O O O O
for O O O O
the O O O O
previous O O O O
spotlight O O O O
is O O O O
available O O O O
[here](https://www.gao.gov/assets/2021-06/GAO-20-583SP_May2020_0.pdf).] O O O O
Vaccines Reason 5 O O
can Reason 5 O O
help Reason 5 O O
save Reason 5 O O
lives Reason 5 O O
and Reason 5 O O
speed Reason 5 O O
economic Reason 5 O O
recovery. Reason 5 O O
U.S.-funded Reason 5 O O
efforts Reason 5 O O
to Reason 5 O O
develop Reason 5 O O
a Reason 5 O O
[COVID-19](https://www.gao.gov/coronavirus) Reason 5 O O
vaccine Reason 5 O O
have Reason 5 O O
led Reason 5 O O
to Reason 5 O O
multiple Reason 5 O O
vaccines Reason 5 O O
available Reason 5 O O
to Reason 5 O O
the Reason 5 O O
public Reason 5 O O
in Reason 5 O O
record Reason 5 O O
time. Reason 5 O O
However, Reason 5 O O
challenges Reason 5 O O
to Reason 5 O O
vaccine Reason 5 O O
development Reason 5 O O
and Reason 5 O O
production Reason 5 O O
remain. Reason 5 O O
For Reason 5 O O
instance, Reason 5 O O
mutations Reason 5 O O
in Reason 5 O O
coronaviruses Reason 5 O O
may Reason 5 O O
require Reason 5 O O
developing Reason 5 O O
new Reason 5 O O
or Reason 5 O O
modified Reason 5 O O
vaccines. Reason 5 O O
Additionally, Reason 5 O O
there Reason 5 O O
are Reason 5 O O
shortages Reason 5 O O
of Reason 5 O O
manufacturing Reason 5 O O
facilities Reason 5 O O
and Reason 5 O O
personnel Reason 5 O O
with Reason 5 O O
specialized Reason 5 O O
skills Reason 5 O O
to Reason 5 O O
run Reason 5 O O
these Reason 5 O O
facilities. Reason 5 O O
[Skip O O O O
to O O O O
Highlights] O O O O
Why O O O O
This O O O O
Matters O O O O
SARS-CoV-2, Reason 3 O O
which Reason 3 O O
causes Reason 3 O O
COVID-19, Reason 3 O O
has Reason 3 O O
killed Reason 3 O O
millions Reason 3 O O
worldwide. Reason 3 O O
Vaccines Reason 3 O O
can Reason 3 O O
help Reason 3 O O
save Reason 3 O O
lives Reason 3 O O
and Reason 3 O O
speed Reason 3 O O
economic Reason 3 O O
recovery. Reason 3 O O
Developing Reason 3 O O
a Reason 3 O O
safe, Reason 3 O O
effective Reason 3 O O
vaccine Reason 3 O O
is Reason 3 O O
a Reason 3 O O
complicated, Reason 3 O O
costly, Reason 3 O O
and Reason 3 O O
typically Reason 3 O O
lengthy Reason 3 O O
process Reason 3 O O
that Reason 3 O O
has Reason 3 O O
historically Reason 3 O O
had Reason 3 O O
a Reason 3 O O
low Reason 3 O O
success Reason 3 O O
rate. Reason 3 O O
U.S.-funded Reason 3 O O
efforts Reason 3 O O
have Reason 3 O O
made Reason 3 O O
several Reason 3 O O
vaccines Reason 3 O O
available Reason 3 O O
to Reason 3 O O
the Reason 3 O O
public Reason 3 O O
in Reason 3 O O
record Reason 3 O O
time. Reason 3 O O
The O O O O
Technology O O O O
What O O O O
is O O O O
it? O O O O
Vaccines O O O O
protect O O O O
people O O O O
from O O O O
disease O O O O
by O O O O
triggering O O O O
the O O O O
immune O O O O
system O O O O
to O O O O
produce O O O O
antibodies O O O O
that O O O O
will O O O O
fight O O O O
the O O O O
pathogen O O O O
attacking O O O O
the O O O O
body. O O O O
In O O O O
the O O O O
case O O O O
of O O O O
COVID-19, O O O O
the O O O O
pathogen O O O O
is O O O O
the O O O O
virus O O O O
SARS-CoV-2. O O O O
Developing O O O O
a O O O O
vaccine O O O O
is O O O O
an O O O O
expensive O O O O
and O O O O
typically O O O O
lengthy O O O O
process O O O O
because O O O O
it O O O O
involves O O O O
a O O O O
rigorous O O O O
series O O O O
of O O O O
steps O O O O
to O O O O
first O O O O
identify O O O O
a O O O O
potential O O O O
vaccine O O O O
"candidate," O O O O
then O O O O
assess O O O O
it O O O O
for O O O O
safety O O O O
and O O O O
effectiveness. O O O O
Billions O O O O
of O O O O
vaccine O O O O
doses O O O O
designed O O O O
to O O O O
fight O O O O
COVID-19 O O O O
have O O O O
already O O O O
been O O O O
administered O O O O
as O O O O
of O O O O
June O O O O
2021 O O O O
across O O O O
the O O O O
U.S. O O O O
and O O O O
the O O O O
world, O O O O
and O O O O
death O O O O
rates O O O O
in O O O O
some O O O O
countries O O O O
have O O O O
dropped O O O O
dramatically. O O O O
How O O O O
does O O O O
it O O O O
work? O O O O
A Reason 3 O O
vaccine Reason 3 O O
can Reason 3 O O
use Reason 3 O O
a Reason 3 O O
pathogen Reason 3 O O
that Reason 3 O O
has Reason 3 O O
been Reason 3 O O
modified Reason 3 O O
to Reason 3 O O
be Reason 3 O O
safe Reason 3 O O
or Reason 3 O O
a Reason 3 O O
molecule Reason 3 O O
that Reason 3 O O
resembles Reason 3 O O
a Reason 3 O O
part Reason 3 O O
of Reason 3 O O
the Reason 3 O O
pathogen, Reason 3 O O
triggering Reason 3 O O
the Reason 3 O O
immune Reason 3 O O
system Reason 3 O O
to Reason 3 O O
produce Reason 3 O O
antibodies. Reason 3 O O
If Reason 3 O O
the Reason 3 O O
vaccinated Reason 3 O O
person Reason 3 O O
is Reason 3 O O
exposed Reason 3 O O
later Reason 3 O O
to Reason 3 O O
the Reason 3 O O
pathogen, Reason 3 O O
their Reason 3 O O
body Reason 3 O O
will Reason 3 O O
produce Reason 3 O O
those Reason 3 O O
antibodies Reason 3 O O
again, Reason 3 O O
increasing Reason 3 O O
their Reason 3 O O
chances Reason 3 O O
of Reason 3 O O
fighting Reason 3 O O
off Reason 3 O O
infection. Reason 3 O O
Development Reason 3 O O
starts Reason 3 O O
with Reason 3 O O
identifying Reason 3 O O
a Reason 3 O O
pathogen Reason 3 O O
"target," Reason 3 O O
such Reason 3 O O
as Reason 3 O O
a Reason 3 O O
protein, Reason 3 O O
that Reason 3 O O
can Reason 3 O O
induce Reason 3 O O
an Reason 3 O O
immune Reason 3 O O
reaction. Reason 3 O O
Researchers Reason 3 O O
create Reason 3 O O
a Reason 3 O O
vaccine Reason 3 O O
candidate Reason 3 O O
similar Reason 3 O O
to Reason 3 O O
that Reason 3 O O
target Reason 3 O O
that Reason 3 O O
will Reason 3 O O
induce Reason 3 O O
production Reason 3 O O
of Reason 3 O O
antibodies Reason 3 O O
effective Reason 3 O O
against Reason 3 O O
the Reason 3 O O
pathogen. Reason 3 O O
The Reason 3 O O
vaccine Reason 3 O O
candidate Reason 3 O O
moves Reason 3 O O
through Reason 3 O O
stages Reason 3 O O
of Reason 3 O O
development, Reason 3 O O
assessment, Reason 3 O O
authorization, Reason 3 O O
and Reason 3 O O
licensure Reason 3 O O
(fig. Reason 3 O O
1). Reason 3 O O
Figure O O O O
1. O O O O
Example O O O O
of O O O O
a O O O O
COVID-19 O O O O
vaccine O O O O
timeline. O O O O
Specific O O O O
steps O O O O
and O O O O
timelines O O O O
may O O O O
vary. O O O O
According O O O O
to O O O O
FDA, O O O O
any O O O O
COVID-19 O O O O
vaccine O O O O
that O O O O
initially O O O O
receives O O O O
an O O O O
emergency O O O O
use O O O O
authorization O O O O
is O O O O
expected O O O O
to O O O O
be O O O O
reviewed O O O O
and O O O O
licensed O O O O
through O O O O
a O O O O
biologics O O O O
license O O O O
application. O O O O
Under O O O O
normal O O O O
circumstances, O O O O
the O O O O
entire O O O O
process O O O O
typically O O O O
takes O O O O
10 O O O O
to O O O O
15 O O O O
years, O O O O
with O O O O
more O O O O
than O O O O
65 O O O O
percent O O O O
of O O O O
candidates O O O O
failing, O O O O
according O O O O
to O O O O
an O O O O
MIT O O O O
study. O O O O
There O O O O
has O O O O
been O O O O
an O O O O
effort O O O O
to O O O O
expedite O O O O
this O O O O
process O O O O
for O O O O
COVID-19 O O O O
vaccines. O O O O
More O O O O
than O O O O
250 O O O O
COVID-19 O O O O
vaccines O O O O
have O O O O
been O O O O
in O O O O
development O O O O
globally. O O O O
Of O O O O
those, O O O O
the O O O O
federal O O O O
government O O O O
awarded O O O O
billions O O O O
of O O O O
dollars O O O O
to O O O O
companies O O O O
for O O O O
the O O O O
development, O O O O
manufacture, O O O O
or O O O O
distribution O O O O
of O O O O
six O O O O
vaccine O O O O
candidates O O O O
under O O O O
a O O O O
partnership O O O O
between O O O O
the O O O O
Departments O O O O
of O O O O
Defense O O O O
(DOD), O O O O
and O O O O
Health O O O O
and O O O O
Human O O O O
Services O O O O
(HHS). O O O O
These O O O O
six O O O O
candidates O O O O
use O O O O
three O O O O
different O O O O
"platforms," O O O O
or O O O O
mechanisms O O O O
to O O O O
prompt O O O O
the O O O O
body O O O O
to O O O O
produce O O O O
antibodies O O O O
(fig. O O O O
2). O O O O
The O O O O
three O O O O
platforms O O O O
generate O O O O
proteins O O O O
that O O O O
mimic O O O O
part O O O O
of O O O O
the O O O O
spike O O O O
protein O O O O
found O O O O
on O O O O
the O O O O
surface O O O O
of O O O O
SARS-CoV-2. O O O O
The O O O O
spike O O O O
protein O O O O
alone O O O O
does O O O O
not O O O O
cause O O O O
a O O O O
COVID-19 O O O O
infection O O O O
but O O O O
may O O O O
be O O O O
sufficient O O O O
to O O O O
produce O O O O
an O O O O
immune O O O O
response. O O O O
Figure Reason 3 O O
2. Reason 3 O O
COVID-19 Reason 3 O O
vaccine Reason 3 O O
candidates Reason 3 O O
use Reason 3 O O
different Reason 3 O O
mechanisms, Reason 3 O O
such Reason 3 O O
as Reason 3 O O
those Reason 3 O O
shown Reason 3 O O
above, Reason 3 O O
to Reason 3 O O
prompt Reason 3 O O
the Reason 3 O O
body Reason 3 O O
to Reason 3 O O
produce Reason 3 O O
antibodies Reason 3 O O
against Reason 3 O O
SARS-CoV-2. Reason 3 O O
The O O O O
first O O O O
platform O O O O
uses O O O O
a O O O O
molecule O O O O
called O O O O
mRNA, O O O O
which O O O O
is O O O O
specifically O O O O
coded O O O O
to O O O O
generate O O O O
proteins O O O O
that O O O O
induce O O O O
an O O O O
immune O O O O
response. O O O O
This O O O O
is O O O O
a O O O O
newer O O O O
method O O O O
of O O O O
vaccine O O O O
development. O O O O
The O O O O
second O O O O
platform O O O O
uses O O O O
recombinant O O O O
proteins, O O O O
which O O O O
are O O O O
produced O O O O
by O O O O
genetically O O O O
engineered O O O O
bacteria O O O O
or O O O O
other O O O O
cells, O O O O
to O O O O
induce O O O O
an O O O O
immune O O O O
response. O O O O
This O O O O
platform O O O O
is O O O O
already O O O O
being O O O O
used O O O O
successfully O O O O
against O O O O
other O O O O
viruses, O O O O
such O O O O
as O O O O
the O O O O
human O O O O
papillomavirus O O O O
(HPV), O O O O
which O O O O
can O O O O
cause O O O O
cervical O O O O
cancer. O O O O
The O O O O
third O O O O
platform O O O O
uses O O O O
another O O O O
virus—called O O O O
adenovirus—removed O O O O
of O O O O
its O O O O
infectious O O O O
aspects, O O O O
making O O O O
it O O O O
safe O O O O
as O O O O
a O O O O
"vector" O O O O
to O O O O
deliver O O O O
a O O O O
piece O O O O
of O O O O
a O O O O
pathogen O O O O
to O O O O
produce O O O O
proteins O O O O
that O O O O
induce O O O O
an O O O O
immune O O O O
response. O O O O
This O O O O
platform O O O O
is O O O O
being O O O O
used O O O O
in O O O O
U.S. O O O O
clinical O O O O
trials O O O O
for O O O O
HIV O O O O
and O O O O
Ebola O O O O
vaccine O O O O
candidates. O O O O
How Reason 3 O O
mature Reason 3 O O
is Reason 3 O O
it? Reason 3 O O
The Reason 3 O O
process Reason 3 O O
for Reason 3 O O
developing Reason 3 O O
a Reason 3 O O
new Reason 3 O O
vaccine Reason 3 O O
as Reason 3 O O
outlined Reason 3 O O
by Reason 3 O O
the Reason 3 O O
Food Reason 3 O O
and Reason 3 O O
Drug Reason 3 O O
Administration Reason 3 O O
(FDA) Reason 3 O O
is Reason 3 O O
well Reason 3 O O
established. Reason 3 O O
In Reason 3 O O
the Reason 3 O O
exploratory Reason 3 O O
stage, Reason 3 O O
the Reason 3 O O
pathogen Reason 3 O O
target Reason 3 O O
and Reason 3 O O
candidate Reason 3 O O
vaccine Reason 3 O O
are Reason 3 O O
identified. Reason 3 O O
In Reason 3 O O
the Reason 3 O O
preclinical Reason 3 O O
stage, Reason 3 O O
researchers Reason 3 O O
use Reason 3 O O
cells Reason 3 O O
and Reason 3 O O
animals Reason 3 O O
to Reason 3 O O
assess Reason 3 O O
safety Reason 3 O O
and Reason 3 O O
produce Reason 3 O O
evidence Reason 3 O O
of Reason 3 O O
clinical Reason 3 O O
promise, Reason 3 O O
evaluated Reason 3 O O
by Reason 3 O O
the Reason 3 O O
candidate's Reason 3 O O
ability Reason 3 O O
to Reason 3 O O
elicit Reason 3 O O
a Reason 3 O O
protective Reason 3 O O
immune Reason 3 O O
response. Reason 3 O O
During Reason 3 O O
clinical Reason 3 O O
trials, Reason 3 O O
the Reason 3 O O
number Reason 3 O O
of Reason 3 O O
people Reason 3 O O
participating Reason 3 O O
is Reason 3 O O
increased Reason 3 O O
at Reason 3 O O
each Reason 3 O O
successive Reason 3 O O
phase. Reason 3 O O
Safety, Reason 3 O O
efficacy, Reason 3 O O
proposed Reason 3 O O
doses, Reason 3 O O
schedule Reason 3 O O
of Reason 3 O O
immunizations, Reason 3 O O
and Reason 3 O O
method Reason 3 O O
of Reason 3 O O
delivery Reason 3 O O
are Reason 3 O O
evaluated. Reason 3 O O
Clinical Reason 3 O O
trials Reason 3 O O
can Reason 3 O O
be Reason 3 O O
terminated Reason 3 O O
for Reason 3 O O
various Reason 3 O O
reasons, Reason 3 O O
including Reason 3 O O
observations Reason 3 O O
of Reason 3 O O
side Reason 3 O O
effects Reason 3 O O
considered Reason 3 O O
to Reason 3 O O
be Reason 3 O O
serious Reason 3 O O
adverse Reason 3 O O
events. Reason 3 O O
For Reason 3 O O
some Reason 3 O O
COVID-19 Reason 3 O O
vaccine Reason 3 O O
candidates, Reason 3 O O
large-scale Reason 3 O O
manufacturing Reason 3 O O
began Reason 3 O O
durin.. Reason 3 O O
